Hamilton Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Hamilton Wealth’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-63,638	Closed	-$10.7M	–	121
2025 Q4	$10.7M	Buy	63,638 +30,051	+89%	+$4.88M	2.04%	15
2025 Q3	$4.85M	Buy	+33,587	New	+$4.58M	1.01%	28
2021 Q4	–	Sell	-31,434	Closed	-$5.08M	–	74
2021 Q3	$5.08M	Buy	31,434 +14,859	+90%	+$2.5M	2.34%	16
2021 Q2	$2.71M	Buy	+16,575	New	+$2.55M	1.27%	24
2020 Q1	–	Sell	-14,457	Closed	-$1.74M	–	39
2019 Q4	$1.74M	Buy	+14,457	New	+$1.61M	1.18%	26
2019 Q3	–	Sell	-2,154	Closed	-$235K	–	41
2019 Q2	$235K	Sell	2,154 -21,798	-91%	-$2.32M	0.17%	41
2019 Q1	$2.68M	Buy	23,952 +2,074	+9%	+$227K	2.12%	17
2018 Q4	$2.11M	Buy	+21,878	New	+$2.32M	2.07%	16

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hamilton Wealth's IBB Position: Q1 2026 in Review

Hamilton Wealth sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 63,638 shares — an estimated $10.7M sold.

Hamilton Wealth first reported a position in IBB in Q4 2018 and held it in 8 quarters. The position peaked at $10.7M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Hamilton Wealth reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Hamilton Wealth sold 63,638 iShares Biotechnology ETF shares in Q1 2026, an estimated $10.7M.
Hamilton Wealth first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 8 quarters.
Hamilton Wealth's iShares Biotechnology ETF position peaked at $10.7M in Q4 2025.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Hamilton Wealth's 13F filing for Q1 2026, filed 18 May 2026.